Foremost Clean Energy Announces National Marketing Campaign
VANCOUVER, British Columbia, April 28, 2025 ( GLOBE NEWSWIRE ) -- Foremost Clean Energy Ltd. ( NASDAQ: FMST ) ( CSE: FAT ) ( "Foremost" or the "Company" ) is pleased to announce the launch of an unprecedented multi-platform investor awareness campaign designed to educate millions of North ...
DLH to Announce Fiscal 2025 Second Quarter Financial Results
ATLANTA, April 28, 2025 ( GLOBE NEWSWIRE ) -- DLH Holdings Corp. ( NASDAQ: DLHC ) ( "DLH" or the "Company" ) , a leading provider of science research and development, systems engineering and integration, and digital transformation and cyber security solutions to federal agencies, will release ...
CareCloud Launches Healthcare AI Center Set to Become World's Largest with 500 AI Professionals
SOMERSET, N.J., April 28, 2025 ( GLOBE NEWSWIRE ) -- CareCloud, Inc. ( Nasdaq: CCLD, CCLDO ) , a leading provider of healthcare technology and generative AI solutions, today announced the official launch of its AI Center of Excellence ( the "AI CoE" ) - a major strategic initiative aimed at ...
Colabor Announces the Date of Its First Quarter 2025 Results Conference Call
SAINT-BRUNO-DE-MONTARVILLE, Quebec, April 28, 2025 ( GLOBE NEWSWIRE ) -- Colabor Group Inc. ( TSX: GCL ) ( "Colabor" or the "Company" ) will release its results for the first quarter ended March 22, 2025, after market close on Thursday, May 1, 2025.
Rigetti Granted Air Force Office of Scientific Research Award to Further Develop Breakthrough Chip Fabrication Technology
The $5.48 million Rigetti-led consortium will include Iowa State University, the Royal Melbourne Institute of Technology, the University of Connecticut, and Lawrence Livermore National Laboratory.
Compass Therapeutics Presents Data on Enhanced Efficacy of CTX-471 in Combination with Tovecimig in Checkpoint-Refractory Models at the American Association for Cancer Research ( AACR ) Annual Meeting
BOSTON, April 28, 2025 ( GLOBE NEWSWIRE ) -- Compass Therapeutics, Inc. ( Nasdaq: CMPX ) , a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics, today announced its poster presentation entitled "Enhanced Efficacy of CTX-471, A CD137 ...
Smart Share Global Limited Files Its Annual Report on Form 20-F
SHANGHAI, April 28, 2025 ( GLOBE NEWSWIRE ) -- Smart Share Global Limited ( Nasdaq: EM ) ( "Energy Monster" or the "Company" ) , a consumer tech company providing mobile device charging service, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, ...
Chemomab Reports New Positive Clinical Data at EASL 2025 Supporting Nebokitug's Impact in Primary Sclerosing Cholangitis and Related Diseases
Chemomab reported new clinical data to be presented at EASL 2025 that further confirms the potential of nebokitug as a first-in-class treatment for PSC.
Mainz Biomed Provides First Quarter 2025 Corporate Update and Path to FDA Premarket Approval
BERKELEY, Calif., April 28, 2025 ( GLOBE NEWSWIRE ) -- Mainz Biomed N.V. ( NASDAQ: MYNZ ) ( "Mainz Biomed" or the "Company" ) , a molecular genetics diagnostic company specializing in the early detection of cancer, today reviewed its major accomplishments of the first quarter of 2025, and ...
iRhythm Presents New Real-World Data on Ambulatory Cardiac Monitoring at HRS 2025 Reinforcing Clinical Superiority of Zio Long-Term Continuous Monitoring
Data show iRhythm Zio LTCM clinical superiority with higher diagnostic yield, fewer retests, and fewer CV events vs. all other LTCMs products ...
